Sanjay Agarwal
Reproductive Endocrinology · la Jolla, CANPI 1255489720
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $216,745 of the $261,666 with a category attached, or 82.8%. AbbVie accounts for 96.1% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $99,125 and has fallen 100.0% since, to $21 in 2025. Among reproductive endocrinology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 213 payments — averaging $1228.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$252K
- Pfizer$10K
- Boston Scientific$131
- Ferring Pharmaceuticals Inc.$32
- Organon$21
Across 7 payments — averaging $44,874 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Swedish Orphan Biovitrum AB$307K
- AbbVie$7K
What the payments were for
- Consulting fees$13,6505%
- Speaking & faculty fees$216,74583%
- Travel & lodging$27,15210%
- Food & beverage$4,0982%
- Education$220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 196 | $251,545 |
| Pfizer | 14 | $9,938 |
| Boston Scientific | 1 | $131 |
| Ferring Pharmaceuticals Inc. | 1 | $32 |
| Organon | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$261,666 in reported general payments places this provider in the 95th percentile of 230 reproductive endocrinology providers in California.
See all reproductive endocrinology providers in California →
Other reproductive endocrinology in la Jolla
- Rachel Whynottla Jolla$16K
- Antoni Dulebala Jolla$14K
- Sharon WinerBeverly Hills$449K
- Valerie FloresSan Diego$184K
- Monica PasternakSan Francisco$77K
- Linda GiudiceSan Francisco$67K
- Valerie BakerSan Jose$66K
- Lisa BechtNewport Beach$48K
- Alexander QuaasSolana Beach$40K
- Shahin GhadirBeverly Hills$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.